Глобальный рынок клеточного скрининга здоровья – тенденции отрасли и прогноз до 2029 года

Анализ и размер рынка скрининга здоровья на основе клеток

Согласно отчетам Всемирной организации здравоохранения, в мире стало больше хронических заболеваний. В 2001 году хронические заболевания составили около 46% от общего мирового бремени болезней и 60% из 56,5 миллионов смертей, произошедших во всем мире. Прогнозируется, что рост хронических заболеваний во всем мире будет способствовать расширению рынка.

Компания Data Bridge Market Research анализирует, что рынок клеточного скрининга здоровья, который в 2021 году составил 2,26 млрд долларов США, к 2029 году вырастет до 5,72 млрд долларов США и, как ожидается, будет испытывать среднегодовой темп роста в размере 12,30% в течение прогнозируемого периода с 2022 по 2029 год. Помимо таких рыночных данных, как рыночная стоимость, темпы роста, сегменты рынка, географический охват, участники рынка и рыночный сценарий, рыночный отчет, подготовленный командой Data Bridge Market Research, также включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Масштаб и сегментация рынка скрининга здоровья на основе клеточных технологий      

Market Definition

Cellular toxicity, fat mass, cellular health and function, intra and extracellular fluid levels, and muscle mass quality can all be determined with the help of cellular health screening.

Cellular Health Screening Market Dynamics

Drivers

• Rise in chronic diseases

The market is anticipated to develop faster as telomere performance programmes become more widely adopted. The market for cellular health screening will grow more quickly between 2022 and 2029 due to a number of additional factors, including an increase in chronic disease cases, an increase in research activities, a growing emphasis on healthy life expectancy, an increase in the population's average age, and an increase in the adoption of digital testing technologies.

• Rise in geriatric population

Growing geriatric population and consequent growth in the need for cellular health screening, rising geriatric population, growing adoption of the direct-to-consumer approach, growing importance of healthy life expectancy (HALE), rising government focus towards preventive healthcare, increasing telomere performance programmes for leading a healthy life, and growing burden of chronic diseases are expected to drive the growth of this market.

Opportunities

The need for testing solutions based on preventative healthcare has increased as a result of an increase in awareness campaigns by organisations around the world. One of the major key factors anticipated to propel market expansion in the near future is collaboration efforts made by organisations like the WHO, CDC, U.S. Preventive Services Task Force, and National Cervical Cancer Coalition to promote cervical cancer screening.

Restraints/Challenges

On the other hand, rising problem associated with the transport of samples, unfavourable reimbursement policies and difference in the cost kit offered by different organization is expected to hamper the market's growth rate.

This cellular health screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cellular health screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Cellular Health Screening Market

Market participants noticed a drop in their sales and base testing volume as a result of the COVID-19 epidemic. Additionally, the pandemic-related government mandates and restrictions on the transportation, export, and import of goods, raw materials, etc. disrupt the supply chain. The demand has decreased as a result, but many businesses have diversified their product lines to include COVID-19 molecular and antibody testing, which can equally counteract the decline in base testing volume.

Global Cellular Health Screening Market Scope

The cellular health screening market is segmented on the basis of type, sample type, and sample collection site. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Single Test Panels
• Telomere Tests
• Oxidative Stress Tests
• Inflammation Tests
• Heavy Metals Tests
• Multi-test Panels

Sample Test

• Blood
• Saliva
• Serum
• Urine

Collection Sites

• Home
• Office
• Hospital
• Diagnostic Labs

 Cellular Health Screening Market Regional Analysis/Insights

The cellular health screening market is analysed and market size insights and trends are provided by country, type, sample type, and sample collection site as referenced above.

The countries covered in the cellular health screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cellular health screening market due to the growing number of geriatric population along with adoption of innovative medical technology.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising ageing population and increasing government initiatives to enhance the healthy lifestyles.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Анализ конкурентной среды и доли рынка скрининга клеточного здоровья

Конкурентная среда рынка скрининга здоровья на основе клеток содержит сведения по конкурентам. Включены сведения о компании, финансы компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта, доминирование приложений. Приведенные выше данные касаются только фокуса компаний, связанного с рынком скрининга здоровья на основе клеток.

Некоторые из основных игроков, работающих на рынке клеточного скрининга здоровья:

• Genova Diagnostics (США)
• Диагностика теломер (США)
• Продолжительность жизни (Испания)
• Quest Diagnostics Incorporated (США)
• Повторите Dx (Канада)
• SpectraCell Laboratories Inc. (США)
• Zimetry (США)
• Системы клеточной науки (США)
• Titanovo, Inc. (США)
• Segterra, Inc. (США)
• Laboratory Corporation of America Holdings (США)
• БиоРеференс (США)
• Иммундиагностик АГ (Германия)
• Cleveland HeartLab, Inc. (США)

SKU-53060